Quant Is Not a Strategy: How to Due Diligence Quant Hedge Funds

By Vincent Weber & Saâdeddine Yahia — Resonanz Capital | Resonance Spotlight: Strategy Notes

The core mistake most allocators make: treating "quant" as an investment strategy rather than a production method. If you don't classify the strategy type before you start underwriting, you will ask the wrong questions, measure the wrong things, and be surprised at the worst possible moment — usually a drawdown.

TL;DR

• "Quant" describes how a strategy is built, not what it does. There are at least five distinct quant strategy types, each with different risk drivers and failure modes.
• Applying a generic framework across all quant funds (Sharpe ratio, max drawdown, correlation to equities) is not due diligence — it is false comfort.
• Classify first, then pressure-test the specific exposures, liquidity profile, and governance framework specific to that strategy type.
• Build your exit framework before you invest — not during a drawdown when emotions are already involved.

Why "Quant" Is Not a Strategy

When allocators hear "quant fund," they often apply a standard checklist: Sharpe ratio, max drawdown, correlation to equities. The problem is that a market-neutral stat arb fund and a trend-following CTA are fundamentally different businesses with completely different failure modes. Asking the same questions of both is not analysis — it is box-ticking.

A market-neutral fund blows up from crowding and short squeezes. A trend-following fund fails during sideways, choppy markets. An Alternative Risk Premium (ARP) portfolio can quietly become a short-volatility trade that drops hard in a credit stress event.

Drawdown alone is not a reason to redeem. Drawdown combined with broken process, exposure drift, or liquidity mismatch — that is a reason.

Understanding the failure mode before you invest is the only way to build a proper exit framework.

The Five Buckets of Quant Strategies

1. Equity Statistical Arbitrage

What it is: High-turnover, high-breadth, long/short equity. The strategy targets market neutrality by capturing micro-inefficiencies — mean reversion and cross-sectional signals. The edge is often as much about execution quality and research speed as it is about any single factor.

Classic failure mode: Crowding plus short squeeze. When many funds share the same short book and that trade goes against them, liquidity disappears precisely when it is needed most. Everyone is trying to cover the same short simultaneously.

What to ask:

• Request monthly factor attribution, not summary statistics. Market neutrality is a claim; factor attribution is the reality. You may find value tilts, momentum tilts, or sector skew — exposures that look fine in normal times but blow up together in stress.
• Ask specifically about the short book: how concentrated is it, what is borrow cost, and what are the limits if a squeeze occurs? The short book is where the risk lives.

Red flag: A manager who says "our machine learning model finds non-linear patterns" but cannot show you data lineage or explain when data was actually available for decision-making. That is leakage risk — the backtest looks great, the live track record is significantly worse.

2. Trend Following (CTAs)

What it is: Time-series momentum in liquid futures — rates, FX, equities, commodities. The pitch is crisis convexity: the fund should appreciate when markets deteriorate badly.

Classic failure mode: It does not deliver that crisis convexity — because trend works in trending markets and fails badly in range-bound, choppy markets. That is not a bug. It is a feature. The problem is allocators buy it expecting steady returns and are shocked when it goes sideways for 18 months.

The hidden risk most allocators miss: Most trend programs use volatility targeting — they scale positions to hit a target volatility. This means when markets become volatile, they sell. When markets calm down, they buy back in. In a stress event, every trend program is selling liquid futures simultaneously to hit their vol targets, which amplifies the move. This is procyclical behavior at the worst moment.

What to ask:

• Understand leverage — not just the average, but the range, and specifically what it looks like after a gap event in rates or FX.
• Understand the execution model: are they trading at close, VWAP? How do they monitor slippage?

Red flag: Crisis alpha claims based on cherry-picked windows. Ask for performance in 2020, 2023, and the 2015 China shock — multiple regimes, not just the three months where trend worked perfectly.

3. Systematic Macro

What it is: Rule-based macro — carry, value, momentum, policy signals, regime classifiers. The key difference from pure trend following is greater complexity, more inputs, more tilts, and sometimes discretionary overlays.

Classic failure mode: Complexity is where it gets dangerous. More degrees of freedom in the model means more ways to fit the backtest. A beautiful historical Sharpe that simply does not survive out-of-sample is the result.

The convergence risk: Systematic macro funds often converge on the same positioning — long duration, long dollar, short emerging markets, long quality equity. When a risk event hits, all of those moves go against you simultaneously, producing a sharp correlation spike.

What to ask:

• "How many versions of this model existed before the current one? What changed, and why?" If the answer is "we improved it" without a clear logical explanation, what you are often hearing is: we backtested our way to better numbers.
• Request scenario P&L under: inflation shock, rates shock, USD squeeze, commodities spike, equity crash. Not theoretical — show how the model would have behaved.

Red flag: Any manager who says "we predict macro." Good systematic macro harvests risk premia and manages positioning dynamically. It does not forecast GDP.

4. Alternative Risk Premia (ARP)

What it is: Systematic harvesting of compensated factors — carry, value, term premium, volatility risk premium, credit spreads. Often delivered in an index-like format with lower fees than traditional hedge funds.

Classic failure mode: An ARP product can quietly become a short-volatility trade or liquidity premium trade with a nasty left tail. It presents as a diversifier in the pitch book, and then in a month where credit stress and rising volatility occur simultaneously, it drops hard.

Practical stress test: Watch high-yield credit spreads and equity implied volatility together. If both are widening and your ARP portfolio is not protected against that combination, you have a hidden short position somewhere.

What to ask:

• Decompose the return stream: what is actually being harvested? Where is the left tail?
• Challenge the fees: if you are paying hedge fund fees for factor exposure that is replicable in a systematic index, that is a structural pricing error. The premia are real — but price them like premia, not like bespoke alpha.

5. Multi-Asset Systematic / Multi-Strat Quant

What it is: A portfolio of systematic sleeves across asset classes and time horizons — trend here, stat arb there, macro somewhere else — with capital allocation happening at the top level.

Classic failure mode: The diversification story sounds compelling in normal markets. Then, in a real stress event, correlations go to one. This is almost always what happens.

What to ask:

• How is risk allocated across sleeves — is it rule-based or discretionary? What triggers de-risking? Sometimes the risk management process is the performance driver, and if you cannot evaluate that process, you are underwriting a black box.
• Ask for risk contribution by sleeve, not notional allocation.
• Ask for liquidity mapping: compare the redemption profile offered to investors against the actual liquidity of the underlying positions. Those two numbers must match. When they do not, you have a structural problem.

Three Questions That Always Matter — Across All Five Buckets

1. Research Process

Ask every manager to answer these in writing:

• How many hypotheses did you test to arrive at the current model?
• What is your process for data leakage control?
• What is the policy for model changes, and who approves them?

If the model changes without documentation, you no longer know what you own. If leakage controls are weak, the track record is not real.

2. Liquidity

Liquidity is not "can I redeem from the fund." It is: can the manager de-risk without moving the market during stress, within the speed implied by my own redemption terms?

Those two things must match. European regulators have been pushing on this explicitly — leverage and liquidity mismatch in alternative funds is a systemic concern, not just an investor-level risk.

3. Governance and Exit Framework

Decide before you invest what would cause you to reduce or exit. Write it down.

Not: "drawdown of X%." Drawdowns happen — that alone is not a reason.

The reason is: drawdown combined with exposure drift, broken execution, or an undocumented model change.

Pre-commit to that framework. If you wait until you are already in a drawdown to decide, emotions are involved and the decision will be worse.

Summary: The Allocator Mistake Is Still the Same

The mistake is buying "quant" as a label instead of underwriting a specific strategy type with a specific failure mode.

The correct sequence:

1. Classify first — which of the five strategy types is this?
2. Pressure-test the specific exposures — not the marketing deck
3. Map liquidity to your investor terms
4. Force transparency on leverage and risk throttles
5. Treat crowding as a variable that changes return distributions — not just volatility risk, but tail risk
6. Price what you are actually buying — if it is premium, pay premium fees, not alpha fees
7. Build your exit framework before you invest, not after

That is what separates a robust systematic allocation from a regretful one.